Search Results - "Wojtacki, J"

Refine Results
  1. 1

    Anthracycline-induced cardiotoxicity: clinical course, risk factors, pathogenesis, detection and prevention--review of the literature by Wojtacki, J, Lewicka-Nowak, E, Leśniewski-Kmak, K

    Published in Medical science monitor (01-03-2000)
    “…Anthracycline antibiotics are widely used antineoplastic agents and their efficacy for the treatment of various haemopoietic or solid tumours has been well…”
    Get more information
    Journal Article
  2. 2

    Overexpression of cathepsin B correlates with angiogenesis in colon adenocarcinoma by Kruszewski, W J, Rzepko, R, Wojtacki, J, Skokowski, J, Kopacz, A, Jaśkiewicz, K, Drucis, K

    Published in Neoplasma (2004)
    “…Some studies have shown the influence of proteases and vascular density in colorectal primary tumors on spreading and on the course of colorectal cancer. In…”
    Get more information
    Journal Article
  3. 3
  4. 4
  5. 5
  6. 6

    Endometrial cancer in patients with breast carcinoma treated with tamoxifen: report of two cases and the literature overview by Sliwińska, M, Wojtacki, J, Sliwiński, W

    Published in Medical science monitor (01-03-2000)
    “…Tamoxifen (TAM) is the endocrine treatment of choice in the first-line therapy for all stages of breast cancer, in both pre- and postmenopausal women. Some…”
    Get more information
    Journal Article
  7. 7
  8. 8

    Evaluation of CA 15-3 tumor marker in the diagnosis of breast cancer: a pilot study by WOJTACKI, J, DZIEWULSKA-BOKINIEC, A, SKOKOWSKI, J, CIESIELSKI, D

    Published in Neoplasma (1994)
    “…Single determinations of serum CA 15-3 levels were performed by sandwich enzyme immunoassay in 160 women: 77 patients with nonmalignant breast tumors (64 had…”
    Get full text
    Journal Article
  9. 9

    The effect of tamoxifen treatment on serum cholesterol fractions in breast cancer women by DZIEWULSKA-BOKINIEC, A, WOJTACKI, J, SKOKOWSKI, J, KORTAS, B

    Published in Neoplasma (1994)
    “…Serum levels of total, free, HDL- and LDL-cholesterol were determined in 45 postmenopausal breast cancer women treated with tamoxifen (TAM) from 6 to 73 months…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Pretreatment values of serum CA 15-3 antigen related to prognostic factors in breast cancer patients by Wojtacki, J, Dziewulska-Bokiniec, A, Kowalski, D M, Zółtowska, A, Ciesielski, D, Suszko, M

    Published in Neoplasma (1996)
    “…In the present study results of serum CA 15-3 immunoassay obtained at diagnosis in 231 breast cancer women (average age: 54.6, range: 27-87 years) were…”
    Get full text
    Journal Article
  12. 12

    Lipoprotein profile in breast cancer women: effect of tamoxifen treatment by DZIEWULSKA-BOKINIEC, A, WOJTACKI, J, SKOKOWSKI, J, WROBLEWSKA, M

    Published in Neoplasma (1994)
    “…Electrophoretic lipoprotein analyses were performed in 51 patients on tamoxifen and compared with those obtained from 33 newly diagnosed breast cancer patients…”
    Get full text
    Journal Article
  13. 13

    p53 expression in breast cancer related to prognostic factors by Ciesielski, D, Dziewulska-Bokiniec, A, Zółtowska, A, Roszkiewicz, A, Kopacz, A, Wojtacki, J

    Published in Neoplasma (1995)
    “…In this article the results of molecular marker p53 examinations were presented in relation to the following established breast cancer prognostic factors: age,…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20